Monocarboxylate Transporter 8 Deficiency: From Pathophysiological Understanding to Therapy Development
Ferdy S van Geest1, Nilhan Gunhanlar1, Stefan Groeneweg1
1Academic Center For Thyroid Disease, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands.
Genetic defects in the thyroid hormone transporter monocarboxylate transporter 8 (MCT8) cause severe intellectual disability and peripheral thyrotoxicosis. Triiodothyroacetic acid shows promise for treating peripheral symptoms, with neurocognitive effects under investigation.
Area of Science:
- Endocrinology
- Neuroscience
- Genetics
Background:
- Monocarboxylate transporter 8 (MCT8) deficiency arises from genetic defects in the MCT8 gene.
- This disorder impairs thyroid hormone transport, leading to severe neurodevelopmental deficits and peripheral thyrotoxicosis.
- MCT8 is vital for thyroid hormone transport across the blood-brain barrier, impacting cerebral signaling.
Purpose of the Study:
- To review the physiological role of MCT8.
- To outline the pathophysiology and clinical characteristics of MCT8 deficiency.
- To discuss current and emerging treatment options for MCT8 deficiency.
Main Methods:
- This review synthesizes current knowledge on MCT8 deficiency.
- It examines the molecular mechanisms, clinical presentations, and therapeutic strategies.
- Literature search and analysis of existing studies on MCT8 and related thyroid hormone transport.
Main Results:
- MCT8 deficiency causes profound intellectual and motor disabilities due to impaired brain thyroid hormone signaling.
- Patients exhibit peripheral thyrotoxicosis from elevated serum T3 levels.
- Poor head control and underweight status correlate with increased mortality.
Conclusions:
- Triiodothyroacetic acid effectively treats peripheral thyrotoxicosis in MCT8 deficiency.
- Further research is needed to evaluate its impact on neurocognitive outcomes.
- Developing novel therapies is crucial for improving patient outcomes and life expectancy.
More Related Videos
07:10Author Spotlight: Expression and Purification of Human Solute Carrier Transporters Using Codon-Optimized Genes
Published on: September 29, 2023
11:27Methods to Study Epithelial Transport Protein Function and Expression in Native Intestine and Caco-2 Cells Grown in 3D
Published on: March 16, 2017
Related Concept Videos
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
ABC Transporters: Exporter
Membrane Transporters
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
